Balance Sheet
Cash Flow Statement
AcquisitionsAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionDivestmentsDividends Paid - CommonExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Growth Metrics
Income Statement
Others
Ratios

Bristol Myers Squibb (BMYMP) Net Cash Flow (2016 - 2025)

Historic Net Cash Flow for Bristol Myers Squibb (BMYMP) over the last 17 years, with Q4 2025 value amounting to -$5.5 billion.

  • Bristol Myers Squibb's Net Cash Flow fell 31195.69% to -$5.5 billion in Q4 2025 from the same period last year, while for Dec 2025 it was -$324.0 million, marking a year-over-year increase of 6869.57%. This contributed to the annual value of -$324.0 million for FY2025, which is 6869.57% up from last year.
  • As of Q4 2025, Bristol Myers Squibb's Net Cash Flow stood at -$5.5 billion, which was down 31195.69% from $3.1 billion recorded in Q3 2025.
  • In the past 5 years, Bristol Myers Squibb's Net Cash Flow ranged from a high of $3.9 billion in Q4 2023 and a low of -$5.5 billion during Q4 2025
  • Its 5-year average for Net Cash Flow is -$236.2 million, with a median of -$116.0 million in 2021.
  • As far as peak fluctuations go, Bristol Myers Squibb's Net Cash Flow soared by 57091.93% in 2021, and later plummeted by 276896.55% in 2022.
  • Bristol Myers Squibb's Net Cash Flow (Quarter) stood at $491.0 million in 2021, then soared by 159.27% to $1.3 billion in 2022, then soared by 204.24% to $3.9 billion in 2023, then plummeted by 32.84% to $2.6 billion in 2024, then crashed by 311.96% to -$5.5 billion in 2025.
  • Its Net Cash Flow stands at -$5.5 billion for Q4 2025, versus $3.1 billion for Q3 2025 and $1.6 billion for Q2 2025.